Mieloproliferatív neopláziák: vizsgálatok itt: Bulgária
7 trials · From ClinicalTrials.gov and EU CTIS (euclinicaltrials.eu), checked 2026. november 18.. Ask the study team whether a trial fits you.
- 4. fázisTaking peopleAsciminib Roll-over Study
- Where
- Pleven, Plovdiv, Sofia, Sofiya, Varna
- Életkor
- 7 év to 100 év
- People
- 347 worldwide
- Run by
- Novartis Pharmaceuticals
See details and how to joinNCT04877522 · EU 2023-507557-16-00 - 3. fázisNot yet taking people in BulgáriaA Study to Compare Elritercept to Placebo in Adults With Myelofibrosis and Anemia Who Are Taking Ruxolitinib
- Where
- Pleven, Plovdiv, Sofia, Sofiya
- Életkor
- 18 év and over
- People
- 324 worldwide
- Run by
- Takeda
See details and how to joinNCT07623161 · EU 2026-525660-17-00 - 1/2. fázisNot yet taking people in BulgáriaA Study of Oral Nuvisertib (TP-3654) in Patients With Myelofibrosis
- Where
- Plovdiv
- Életkor
- 18 év and over
- People
- 240 worldwide
- Run by
- Sumitomo Pharma America, Inc.
See details and how to joinNCT04176198 · EU 2022-502597-16-00 - 2. fázisFut, nem toborozA Phase 2 study to evaluate the efficacy and safety of selinexor monotherapy in subjects with JAK inhibitor-naïve myelofibrosis and moderate thrombocytopenia.
- Where
- Plovdiv, Sofia, Sofiya, Stara Zagora
- Életkor
- 18 év and over
- People
- 38 worldwide
- Run by
- Karyopharm Therapeutics Inc.
See details and how to join2024-511309-47-00 - 3. fázisBefejeződöttA Study to Evaluate Long-term Safety in Participants Who Have Participated in Other Luspatercept (ACE-536) Clinical Trials
- Where
- Boulevard, Plovdiv
- Életkor
- 18 év and over
- People
- 665 worldwide
- Run by
- Celgene
See details and how to joinNCT04064060 - 3. fázisFut, nem toborozStudy on Efficacy and Safety of Givinostat Versus Hydroxyurea in Patients With Polycythemia Vera
- Where
- Plovdiv, Sofia, Stara Zagora
- Életkor
- 18 év and over
- People
- 220 worldwide
- Run by
- Italfarmaco
See details and how to joinNCT06093672 · EU 2022-502276-23-00 - 2. fázisTaking peopleA Study of Selinexor Monotherapy in Subjects With JAK Inhibitor-naïve Myelofibrosis and Moderate Thrombocytopenia
- Where
- Plovdiv, Sofia, Stara Zagora
- Életkor
- 18 év and over
- People
- 58 worldwide
- Run by
- Karyopharm Therapeutics Inc
See details and how to joinNCT05980806